Quantification of viral load: Clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection

Intervirology

Volumn 41, Issue 1, 1998, Pages 24-34

  Berger, Annemarie ^a   Braner, Jens ^a   Doerr, Hans Wilhelm ^a   Weber, Bernard ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Laboratoires Reunis Kutter Lieners Hastert Centre Langwies   (Luxembourg)

Author keywords

Antiviral therapy monitoring; Branched DNA; Genetic variability; Nucleic acid sequence based amplification; Polymerase chain reaction; Prognostic marker

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; GENETIC VARIABILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DNA, VIRAL; HEPATITIS B; HEPATITIS C; HUMANS; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, VIRAL;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031670052     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024912     Document Type: Article

References (68)

1. Wei X, Ghosh SK, Taylor MD, Johnson VA, Emini EA, Deutsch P, Lifson JD, Borhoelter S, Nowoz MA, Hahn BH, et al: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4+ lymphocytes in HIV-1 infection. Nature 1995;373:123-126.
3. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271: 1582-1586.
4. Stein DS, Korvick JA, Vermud SH: CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review. J Infect Dis 1992;165:352-363.
5. Raboud JM, Montaner JS, Conway B, Haley L, Sherlock C, O'Shaughnessy MV, Schechter MT: Variation in plasma RNA levels. CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J Infect Dis 1996;174:191-194.
6. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
7. O'Brien TR, Blattner WA, Waters D, Eyster E, Higartner MW, Cohen AR, Luban N, Hatzakis A, Aledorf LM, Rosenberg PS, Miley WJ, Kroner BL, Goedert JJ: Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 1996;276:105-110.
8. O'Brien WA, Hartigon PM, Martin D, Eschhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334:425-431.
9. Saksela K, Stevens CE, Rubinstein P, Taylor PE, Baltimore D: HIV-1 messenger RNA in peripheral blood mononuclear cells as early-marker of risk for progression to AIDS. Ann Intern Med 1995;123:641-648.
10. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA: HIV viral load markers in clinical practice. Nat Med 1996;2:625-629.
11. Hammer SM, Katzenstein DA, Hughes MD, Gundockz H, Schooley RT, Haubich RH, Henry WK, Lederman HM, Phair JP, Niu M, Hirch MS, Merigan TC: A trial comparing monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996;335:1081-1090.
12. Decks SG, Coleman RL, White R, Pachl C, Schambelan M, Chernoff DN, Feinberg MB: Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J Infect Dis 1997;176:514-517.
13. Brambilla D, Leung S, Lew J, Todd J, Herman S, Cronin M, Shapiro DE, Bremer J, Hanson C, Hillyer GV, McSherry GD, Sperling RS, Coombs RW, Reichelderfer PS: Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: Effect of an external standard on kit comparisons. J Clin Microbiol 1998;36:311-314.
14. Yen-Liebermann B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, Herman S, Katzenstein D, Leung S, Lin HJ, Palumbo P, Rasheed S, Todd J, Vahey M, Reichelderfer P: Evaluation of a quality assurance program for quantification of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol 1996;34:2695-2701.
15. DVV; GfV, DGHM, INSTAND: Ringversuch Virusgenom-Nachweis - Polymerase Chain Reaction (PCR) und andere Nukleinsäure-Amplifikationstechniken (NAT) zum Nachweis von HIV-1 RNA. Programm C, Gruppe 3690, Juli/August 1997.
16. ™ test. 4th Conference on Retroviruses and Opportunistic Infections, Feb, 1997.
17. Weber B, Melchior W, Preiser W, Hess G, Wahl M, Braner J, Doerr HW: Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: Comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA. J Clin Microbiol 1996;34:1440-1447.
18. Larder BA, Kemp SD: Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989; 246:1155-1158.
19. Kellam P, Larder BA: Recombinant virus assay: A rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother 1994;37:1095-1101.
20. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobson DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA: Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997;277:1962-1969.
21. Scarlatti G: Paediatric HIV infection. Lancet 1996;348:863-868.
22. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-1012.
23. Fang G, Burger H, Grimson R, Tropper P, Nahman S, Mayers D, Weislow O, Moore R, Reyelt CL, Hutcheon N: Maternal plasma human immunodeficiency virus type 1 RNA levels: A determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92:12100-12104.
24. Palumbo PE, Kwok S, Waters S, et al: Viral measurement by polymerase chain reaction-based assays in HIV-iniected infants. J Pediatr 1995;126:192-195.
25. Krivine A, Le Bourdelles S, Firtion G, Lebon P: Viral kinetics in HIV-1 perinatal infection. Lancet 1997;350:493.
26. Steketee RW, Abrams EJ, Thea DM, Brown TM, Lambert G, Orloff S, Weedon J, Bamji M, Schoenbaum EE, Rapier J, Kalish ML: Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. J Infect Dis 1997;175:707-711.
27. Weber B: Aktuelle Entwicklungen in der Diagnostik der HIV-Infektion. AIDS Forschung 1995;10:339-349.
28. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sulivan JL: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Padiatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996;335:1621-1629.
29. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich D: The serology of chronic hepatitis B infection revisited. J Clin Invest 1993;91:2586-2595.
30. Carman WF, Fagan EA, Hadziyannis S: Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis. Hepatology 1991;14:219-222.
31. Perrillo R, Mimms L, Schechtman K, Robbins D, Campbell C: Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing. Hepatology 1993;18:1306-1312.
32. Perrillo RP, Schiff ER, Davis Gl, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM: A randomized, controlled trial of treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
33. Hofmann H, Tuma W, Heinz FX, Kunz C: Relevance of hepatitis B DNA detection in patient's serum. Zentralbl Bakteriol 1990;272: 485-497.
34. Weber B, Doerr HW: Bedeutung von anti-HBc-IgM für die Diagnose und Verlaufskontrolle der Hepatitis B: aktuelle Entwicklungen. J Lab Med 1996;20:390-394.
35. Hollinger FB: Hepatitis B virus; in Fields BN, Knipe DM, Howley PM (eds): Virology, ed 3. Philadelphia, Lippincott-Raven, 1996, pp 2739-2807.
36. Zaaijer HL, Ter Borg F, Cuypers HTM, Hermus MCAH, Lelie PN: Comparison of differ ent methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994;32:2088-2091.
37. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL: 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343: 142-146.
38. Quint WG, Heltjink RA, Schirm J, Gerlich WH, Niesters HG: Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995;33:225-228.
39. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, Brechot C: Transmission of hepatitis B from hepatitis B-seronegative subjects. Lancet 1988;ii:1273-1276.
40. Lai KN, Lai FMM, Leung NWY, Lo S, Tam JS: Hepatitis with isolated serum antibody to hepatitis B core antigen. Am J Clin Pathol 1990; 93:79-83.
41. Gross A, Joller-Jemelka HI, Wicki AN, Grob PJ: Der hepatitisserologische Befund 'Anti-HBc allein', zirkulierende virale DNS und Befund-Interpretation. Schweiz Med Wochenschr 1993;123:1193-1202.
42. Sanchez-Quijano, A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, Garcia de Pesquera F, Prieto J, Lissen E: Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 1993;17:288-293.
43. Sumazaki, R, Motz M, Wolf H, Heinig J, Jilg W, Deinhardt F: Detection of hepatitis B virus in serum using amplification of DNA by means of polymerase chain reaction. J Med Virol 1989;27:304-308.
44. Wang, JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS: Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163:397-399.
45. Jilg W, Sieger E, Zachoval R, Schätzl R: Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus. J Hepatol 1995;23:14-20.
46. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
47. Simmonds P: Variability of hepatitis C genome: in Resink HW (ed): Hepatitis C Virus. Basel Karger, 1994, pp 12-35.
48. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Urdea MS, Holmes EC: Identification of genotypes of hepatitis C virus by sequence comparisons in the core. E1 and NS-5 regions. J Gen Virol 1994;75:1053-1061.
49. Berger A, von Depka-Prondzinski M, Doerr HW, Rabenau H, Weber B: Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol 1996; 48:339-343.
50. Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992;339:1543.
51. Takada N, Takase S, Enomoto N, Takada A, Date T: Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992;14:35-40.
52. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T: Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992;16: 293-299.
53. Reichard O, Norkrans G, Fryden A, Braconier JH, Sönnerborg A, Weiland O, Swedish Study Group: Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-87.
54. Poynard Th, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349: 825-832.
55. Chemello LA, Alberti A, Rose K, Simmonds P: Hepatitis C serotype and response to interferon therapy. N Engl J Med 1994;330:143.
56. Pozzato G, Moretti M, Croce LS, Sasso F, Kaneko S, Unoura M, Kobayashi K, Crovatto M, Santini G, Tiribelli C: Interferon therapy in chronic hepatitis C: Evidence of different outcome with respect to different viral strains. J Med Virol 1995;45:445-450.
57. Berger A, Scharrer I, Doerr HW, Hess G, Weber B: Infection with hepatitis G virus in immunoglobulin recipients. Lancet 1997;349: 207.
58. Berger A, Doerr HW, Scharrer I, Weber B: Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: Evidence for HCV but not for GBV-C/HGV transmission. J Med Virol 1997;53/1:25-30.
59. Lin HH, Kao JH, Hsu HY, Ni YH, Yen SH, Hwang LH, Chang MH, Hwang SC, Chen PJ, Chen DS: Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994;169:638-641.
60. Wejstäl R, Hermodsson S, Iwarson S, Norkrans G: Mother to infant transmission of hepatitis C virus infection. J Med Virol 1990;30:178-180.
61. Eyster ME, Fried MW, Di Besceglie AM, Goedert JJ: Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020-1023.
62. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for the detection of hepatitis C virus. Lancet 1993;341:722-724.
63. Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niester HGM, Lelie PN: International collaborative study on the Eurohep HCV RNA reference panel. J Virol Methods 1996;58:175-185.
64. Hawkins A, Davidson F, Simmonds P: Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay, and in-house limiting dilution method. J Clin Microbiol 1997;35:187-192.
65. Collins ML, Zayati C, Detmer JJ, Daly B, Klolberg JA, Cha TA, Irvine BD, Tucker J, Urdea MS: Preparation and characterization of RNA standards for use in quantitative bDNA hybridization assays. Annal Biochem 1995;226: 120-129.
66. Lau JYN, Simmonds P, Urdea MS: Implications of variations of 'conserved' regions of hepatitis C virus genome. Lancet 1995;346: 425-426.
67. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, Urdea M, Sanchez-Pescador R: Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996;34:901-907.
68. Hopf U, Niederau C, Kleber G, Fleig WE. Konsensusbericht/Consensus Report: Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C -Konsensus der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 1997;35:971-986.